IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the ...

Did you analyze how IQVIA Holdings (IQV) fared in its international operations for the quarter ending December 2024? Given the widespread global presence of this clinical testing company ...

Q4 2024 Earnings Call Transcript February 6, 2025 IQVIA Holdings Inc. beats earnings expectations. Reported EPS is $3.12, expectations were $3.11. Operator: Ladies and gentlemen, thank you for ...

How Virtual Clinical Trials Are Speeding The Path To Another Vaccine For decades, IQVIA has been helping pharmaceutical giants perform clinical trials to test new treatments. The company combines ...

(RTTNews) - While reporting financial results for the fourth quarter on Wednesday, life sciences services company IQVIA Holdings Inc. (IQV) initiated its adjusted earnings and revenue guidance for ...

Evercore ISI analyst Elizabeth Anderson CFA maintained a Buy rating on IQVIA Holdings (IQV – Research Report) on February 7 and set a price target of $245.00. The company’s shares closed last ...

In a report released today, Luke Sergott from Barclays maintained a Buy rating on IQVIA Holdings (IQV – Research Report), with a price target of $235.00. The company’s shares closed yesterday ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

At this time, I would like to welcome everyone to the IQVIA Fourth Quarter 2024 Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...